Obesity management for patients with coronary artery disease and heart failure
Syed, A. A. ; Adam, S. ; Miller, C. A. ; Alkhaffaf, B.
Syed, A. A.
Adam, S.
Miller, C. A.
Alkhaffaf, B.
Abstract
Obesity is causally linked to heart disease directly by triggering various adverse pathophysiological changes and indirectly through convergent risk factors such as type 2 diabetes, hypertension, dyslipidemia, and sleep disorder. Weight reduction is an important intervention for obesity-related cardiomyopathy, and antiobesity medications that target both obesity and heart failure (HF), particularly sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, have a role in treatment. Bariatric surgery offers a viable treatment option for patients with severe obesity associated with coronary artery disease and HF but requires careful patient selection, preoperative optimization, choice of procedure, and postoperative management to minimize risks.
Description
Date
2025
Publisher
Collections
Keywords
Type
Article
Citation
Syed AA, Adam S, Miller CA, Alkhaffaf B. Obesity management for patients with coronary artery disease and heart failure. Heart failure clinics. 2025 Apr;21(2):257-71. PubMed PMID: 40107803. Epub 2025/03/20. eng.